Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1|1|2|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-2|1|2|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-3|1|2|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-4|1|2|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-5|1|3|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-6|1|5|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-7|1|7|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-8|1|7|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-9|1|9|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-10|1|9|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-11|1|9|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-12|1|10|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-13|1|14|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-14|1|14|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-15|1|15|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-16|1|16|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-17|1|16|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-18|1|16|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-19|1|16|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-20|1|23|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-21|1|25|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-22|1|25|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-23|1|25|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-24|1|25|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-25|1|26|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-26|1|27|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-27|1|29|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-28|1|29|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-29|1|29|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-30|1|29|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-31|1|30|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-32|1|31|Neoplasia malignant|Other local manifestations and miscellaneus|benign|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-33|1|32|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-34|1|33|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-35|1|35|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-36|1|37|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-37|1|37|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-38|1|38|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-39|1|42|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-40|1|43|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-41|1|44|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-42|1|44|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-43|1|44|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-44|1|44|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-45|1|45|Neoplasia malignant|Lower digestive tract,MA: 0000353 - stomach|benign,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-46|1|46|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-47|1|46|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-48|1|46|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-49|1|46|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-50|1|50|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-51|1|50|Neoplasia malignant|Other local manifestations and miscellaneus|benign|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-52|1|50|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-53|1|50|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-54|1|50|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-55|1|50|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-56|1|52|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-57|1|52|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-58|1|53|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-59|1|60|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-60|1|60|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-61|1|60|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-62|1|73|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-63|1|73|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-64|1|73|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 219 - adnexal and skin appendage tumor|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-65|1|81|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-66|1|81|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-67|1|81|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-68|1|81|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-69|1|81|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-70|1|85|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-71|1|145|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-72|1|145|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-73|1|184|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-74|1|192|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-75|1|271|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-76|1|292|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-77|1|307|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-78|1|322|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-79|1|322|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-80|1|322|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-81|1|322|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-82|1|322|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-83|1|322|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-84|1|322|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-85|1|322|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-86|1|322|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-87|1|365|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-88|1|389|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-89|1|397|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-90|1|397|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-91|1|397|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-92|1|397|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-93|1|397|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-94|1|399|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-95|1|400|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-96|1|401|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-97|1|403|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-98|1|404|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-99|1|406|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-100|1|408|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-101|1|416|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-102|1|419|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-103|1|419|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-104|1|421|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-105|1|422|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-106|1|428|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-107|1|429|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-108|1|438|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-109|1|440|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-110|1|443|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-111|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-112|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-113|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-114|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-115|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-116|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-117|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-118|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-119|1|457|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-120|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-121|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-122|1|457|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-123|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-124|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-125|1|457|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-126|1|464|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-127|1|471|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-128|1|477|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-129|1|480|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-130|1|482|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-131|1|484|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-132|1|486|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-133|1|487|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-134|1|487|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-135|1|489|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-136|1|492|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-137|1|493|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-138|1|493|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-139|1|495|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-140|1|498|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-141|1|498|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-142|1|499|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-143|1|505|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-144|1|505|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-145|1|506|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-146|1|513|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-147|1|516|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-148|1|518|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-149|1|520|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-150|1|520|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-151|1|523|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-152|1|524|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|metastatic,MPATH: 219 - adnexal and skin appendage tumor|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-153|1|526|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-154|1|527|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-155|1|527|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-156|1|527|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-157|1|527|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-158|1|532|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-159|1|532|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-160|1|532|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-161|1|533|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-162|1|537|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-163|1|538|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-164|1|539|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-165|1|540|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-166|1|541|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-167|1|542|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-168|1|542|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-169|1|542|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-170|1|543|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-171|1|544|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-172|1|545|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-173|1|547|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-174|1|547|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-175|1|549|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-176|1|549|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-177|1|550|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-178|1|552|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-179|1|552|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-180|1|552|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-181|1|553|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-182|1|555|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-183|1|556|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-184|1|556|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-185|1|558|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-186|1|562|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-187|1|562|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-188|1|562|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-189|1|567|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-190|1|567|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-191|1|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-192|1|567|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-193|1|568|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-194|1|571|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-195|1|571|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-196|1|572|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-197|1|572|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-198|1|575|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-199|1|576|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-200|1|577|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-201|1|577|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-202|1|577|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-203|1|579|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-204|1|580|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-205|1|582|Neoplasia malignant|Other local manifestations and miscellaneus|benign|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-206|1|584|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-207|1|584|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-208|1|586|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-209|1|586|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-210|1|586|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-211|1|588|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-212|1|588|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-213|1|588|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-214|1|591|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-215|1|591|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-216|1|591|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-217|1|591|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|benign,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-218|1|591|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-219|1|591|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|benign,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-220|1|591|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-221|1|591|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-222|1|592|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-223|1|592|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-224|1|594|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-225|1|597|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-226|1|597|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-227|1|598|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-228|1|599|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-229|1|599|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|metastatic,MPATH: 409 - fibrous histiocytoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-230|1|601|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-231|1|602|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-232|1|602|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-233|1|602|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-234|1|602|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-235|1|602|Neoplasia unclassified|Nervous system and special sense organs,MA: 0002565 - sebaceous gland|,MPATH: 218 - neoplasm|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-236|1|602|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-237|1|605|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-238|1|605|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-239|1|606|Neoplasia malignant|Reproductive system,MA: 0000404 - prostate gland|,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-240|1|607|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-241|1|608|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-242|1|609|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-243|1|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-244|1|611|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-245|1|611|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-246|1|611|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-247|1|611|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-248|1|612|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-249|1|612|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-250|1|612|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-251|1|612|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-252|1|613|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-253|1|614|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-254|1|615|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-255|1|616|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-256|1|617|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-257|1|619|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-258|1|620|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-259|1|620|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-260|1|622|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-261|1|622|Neoplasia benign|Bloodvessels among cardiovascular system|benign|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-262|1|623|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-263|1|623|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-264|1|623|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-265|1|624|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-266|1|624|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-267|1|625|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-268|1|626|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-269|1|626|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-270|1|626|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-271|1|626|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-272|1|627|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-273|1|627|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-274|1|628|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-275|1|628|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-276|1|629|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-277|1|630|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-278|1|632|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-279|1|632|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-280|1|632|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-281|1|632|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-282|1|632|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-283|1|633|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-284|1|634|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-285|1|634|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-286|1|635|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-287|1|635|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-288|1|636|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-289|1|636|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-290|1|636|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-291|1|637|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-292|1|637|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-293|1|638|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-294|1|638|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-295|1|638|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-296|1|639|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-297|1|640|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-298|1|641|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-299|1|642|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-300|1|642|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-301|1|642|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-302|1|643|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-303|1|643|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-304|1|643|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-305|1|643|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-306|1|647|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-307|1|647|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-308|1|647|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-309|1|648|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-310|1|648|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-311|1|649|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-312|1|649|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-313|1|649|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-314|1|650|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-315|1|650|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-316|1|650|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-317|1|650|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-318|1|651|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-319|1|651|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-320|1|652|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-321|1|652|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-322|1|655|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-323|1|655|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-324|1|656|Neoplasia unclassified|Lower respiratory system,MA: 0000032 - thoracic cavity|,MPATH: 238 - hemangioblastoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-325|1|657|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-326|1|657|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-327|1|657|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-328|1|657|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-329|1|658|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-330|1|658|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-331|1|659|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-332|1|659|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-333|1|659|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-334|1|659|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-335|1|659|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-336|1|661|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-337|1|661|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-338|1|661|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-339|1|662|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-340|1|662|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-341|1|663|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-342|1|663|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-343|1|664|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-344|1|664|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-345|1|666|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-346|1|666|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-347|1|666|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-348|1|667|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-349|1|667|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-350|1|667|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-351|1|668|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-352|1|670|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-353|1|671|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-354|1|671|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-355|1|672|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-356|1|673|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-357|1|674|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-358|1|675|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-359|1|675|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-360|1|676|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-361|1|677|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-362|1|677|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-363|1|677|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-364|1|678|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-365|1|678|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-366|1|679|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-367|1|679|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-368|1|680|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-369|1|680|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-370|1|680|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-371|1|681|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-372|1|681|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-373|1|682|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-374|1|682|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-375|1|682|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-376|1|683|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-377|1|683|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-378|1|684|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-379|1|684|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-380|1|684|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-381|1|685|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-382|1|685|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-383|1|687|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-384|1|687|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-385|1|687|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-386|1|687|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-387|1|688|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-388|1|689|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-389|1|690|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-390|1|692|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-391|1|692|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-392|1|693|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-393|1|693|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-394|1|693|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-395|1|695|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-396|1|695|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-397|1|695|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-398|1|696|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-399|1|696|Neoplasia unclassified|Nervous system and special sense organs,MA: 0002565 - sebaceous gland|,MPATH: 218 - neoplasm|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-400|1|696|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|metastatic,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-401|1|699|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-402|1|699|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-403|1|700|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-404|1|700|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-405|1|700|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-406|1|700|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-407|1|701|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-408|1|701|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-409|1|702|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-410|1|702|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-411|1|702|Neoplasia malignant|Lymphatic vessels among cardiovascular system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-412|1|704|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-413|1|705|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-414|1|706|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-415|1|706|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-416|1|707|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-417|1|707|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-418|1|707|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-419|1|707|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-420|1|708|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-421|1|709|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-422|1|709|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-423|1|710|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-424|1|710|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-425|1|710|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-426|1|710|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-427|1|710|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-428|1|710|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-429|1|710|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-430|1|710|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-431|1|711|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-432|1|711|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-433|1|711|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-434|1|712|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-435|1|712|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-436|1|713|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-437|1|714|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-438|1|714|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-439|1|714|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-440|1|715|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-441|1|715|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|benign,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-442|1|716|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-443|1|716|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-444|1|716|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-445|1|716|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-446|1|716|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-447|1|716|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-448|1|717|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-449|1|717|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-450|1|718|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-451|1|718|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-452|1|720|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-453|1|720|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-454|1|720|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-455|1|721|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-456|1|721|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-457|1|721|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-458|1|722|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-459|1|722|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-460|1|722|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-461|1|723|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-462|1|727|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-463|1|727|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-464|1|727|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-465|1|727|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-466|1|727|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-467|1|727|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-468|1|727|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-469|1|728|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-470|1|728|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-471|1|728|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|metastatic,MPATH: 426 - leiomyosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-472|1|729|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-473|1|729|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-474|1|729|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-475|1|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-476|1|730|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-477|1|730|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-478|1|731|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-479|1|732|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-480|1|732|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-481|1|732|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-482|1|732|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-483|1|732|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-484|1|732|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-485|1|732|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-486|1|732|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-487|1|733|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-488|1|734|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-489|1|734|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-490|1|734|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-491|1|735|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-492|1|735|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-493|1|735|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-494|1|736|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-495|1|738|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-496|1|738|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-497|1|739|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-498|1|739|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-499|1|739|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-500|1|741|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-501|1|741|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-502|1|741|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-503|1|741|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-504|1|742|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|benign,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-505|1|743|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-506|1|743|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 409 - fibrous histiocytoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-507|1|744|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-508|1|744|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-509|1|744|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-510|1|744|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-511|1|744|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-512|1|744|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-513|1|744|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-514|1|744|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-515|1|744|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-516|1|745|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-517|1|745|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-518|1|746|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-519|1|746|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-520|1|746|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-521|1|746|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-522|1|748|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-523|1|748|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-524|1|749|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-525|1|749|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-526|1|750|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-527|1|750|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-528|1|750|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-529|1|750|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-530|1|751|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-531|1|751|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-532|1|752|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-533|1|753|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-534|1|753|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-535|1|754|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-536|1|756|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-537|1|756|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-538|1|756|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-539|1|756|Neoplasia unclassified|Nervous system and special sense organs,MA: 0002565 - sebaceous gland|,MPATH: 218 - neoplasm|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-540|1|757|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-541|1|757|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-542|1|757|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-543|1|757|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-544|1|758|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-545|1|759|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-546|1|759|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-547|1|759|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-548|1|759|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-549|1|759|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-550|1|759|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-551|1|759|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-552|1|759|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-553|1|759|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-554|1|760|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-555|1|760|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-556|1|761|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-557|1|761|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-558|1|761|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-559|1|762|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-560|1|762|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-561|1|762|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-562|1|762|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-563|1|762|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-564|1|762|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-565|1|762|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-566|1|762|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-567|1|762|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-568|1|763|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-569|1|764|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-570|1|764|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-571|1|765|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-572|1|765|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-573|1|765|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-574|1|765|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-575|1|766|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-576|1|766|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-577|1|766|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-578|1|766|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-579|1|766|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-580|1|766|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-581|1|767|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-582|1|767|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-583|1|769|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-584|1|769|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-585|1|770|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-586|1|771|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-587|1|771|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-588|1|771|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-589|1|772|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-590|1|772|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-591|1|773|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-592|1|773|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-593|1|773|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-594|1|773|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-595|1|773|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-596|1|773|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-597|1|774|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-598|1|774|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-599|1|774|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-600|1|774|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-601|1|775|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-602|1|776|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-603|1|777|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-604|1|777|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|benign,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-605|1|777|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-606|1|777|Neoplasia malignant|Lower digestive tract,MA: 0000353 - stomach|,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-607|1|778|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-608|1|778|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-609|1|778|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-610|1|779|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-611|1|779|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-612|1|779|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-613|1|780|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-614|1|780|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-615|1|780|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-616|1|781|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-617|1|781|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-618|1|781|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-619|1|781|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-620|1|781|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-621|1|781|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-622|1|782|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-623|1|783|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-624|1|783|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-625|1|784|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-626|1|784|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-627|1|784|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-628|1|785|Neoplasia malignant|Lymphatic vessels among cardiovascular system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-629|1|785|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-630|1|785|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-631|1|786|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-632|1|786|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-633|1|786|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-634|1|787|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-635|1|787|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-636|1|788|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-637|1|788|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-638|1|788|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-639|1|790|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-640|1|790|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-641|1|790|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-642|1|790|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-643|1|791|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-644|1|792|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-645|1|792|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-646|1|792|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-647|1|793|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-648|1|793|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-649|1|794|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-650|1|794|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|benign,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-651|1|795|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-652|1|795|Neoplasia malignant|Liver among hepato-pancreatic system diseases|benign|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-653|1|795|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-654|1|797|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-655|1|797|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-656|1|797|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-657|1|797|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-658|1|797|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-659|1|797|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-660|1|797|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-661|1|798|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-662|1|798|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-663|1|798|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-664|1|798|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-665|1|798|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-666|1|800|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-667|1|800|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-668|1|800|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-669|1|800|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-670|1|800|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-671|1|800|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|benign,MPATH: 242 - hemangiosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-672|1|800|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-673|1|800|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-674|1|800|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-675|1|801|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-676|1|801|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-677|1|801|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-678|1|802|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-679|1|804|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-680|1|804|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-681|1|804|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-682|1|805|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-683|1|805|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-684|1|805|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-685|1|805|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-686|1|806|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-687|1|806|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-688|1|806|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-689|1|806|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-690|1|806|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-691|1|807|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-692|1|807|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-693|1|808|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-694|1|808|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-695|1|809|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-696|1|809|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-697|1|809|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-698|1|810|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-699|1|811|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-700|1|812|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-701|1|813|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-702|1|813|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-703|1|813|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-704|1|814|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-705|1|814|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-706|1|814|Neoplasia unclassified|Nervous system and special sense organs,MA: 0002565 - sebaceous gland|,MPATH: 218 - neoplasm|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-707|1|815|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-708|1|815|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-709|1|815|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-710|1|815|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-711|1|816|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-712|1|817|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-713|1|817|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-714|1|817|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-715|1|818|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-716|1|818|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-717|1|819|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-718|1|819|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-719|1|819|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-720|1|819|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-721|1|819|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-722|1|819|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-723|1|820|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-724|1|820|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-725|1|821|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-726|1|822|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-727|1|822|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-728|1|822|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-729|1|822|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-730|1|822|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-731|1|823|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-732|1|824|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-733|1|825|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-734|1|825|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-735|1|825|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-736|1|825|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-737|1|826|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-738|1|826|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-739|1|826|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-740|1|826|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-741|1|826|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-742|1|826|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-743|1|827|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-744|1|827|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-745|1|827|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-746|1|827|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-747|1|827|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-748|1|828|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-749|1|828|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-750|1|828|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-751|1|828|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-752|1|829|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-753|1|830|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-754|1|830|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-755|1|832|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-756|1|833|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-757|1|833|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-758|1|834|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-759|1|834|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-760|1|835|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-761|1|836|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-762|1|836|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-763|1|837|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-764|1|837|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-765|1|839|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-766|1|839|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-767|1|839|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-768|1|840|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-769|1|840|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-770|1|840|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-771|1|841|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-772|1|841|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-773|1|842|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-774|1|842|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-775|1|842|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-776|1|842|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-777|1|842|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-778|1|843|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-779|1|844|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-780|1|844|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-781|1|844|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-782|1|844|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-783|1|845|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-784|1|845|Neoplasia unclassified|Reproductive system,MA: 0002420 - gonad|,MPATH: 322 - teratoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-785|1|845|Neoplasia benign|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-786|1|846|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-787|1|846|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-788|1|846|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-789|1|846|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-790|1|846|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-791|1|846|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-792|1|847|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-793|1|847|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-794|1|848|Neoplasia malignant|Bloodvessels among cardiovascular system|benign|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-795|1|849|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-796|1|849|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-797|1|849|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-798|1|849|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-799|1|849|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-800|1|850|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-801|1|850|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-802|1|851|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-803|1|851|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-804|1|851|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-805|1|852|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-806|1|852|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-807|1|852|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-808|1|852|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-809|1|853|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-810|1|853|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-811|1|853|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-812|1|853|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-813|1|853|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-814|1|853|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-815|1|853|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-816|1|853|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-817|1|853|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-818|1|854|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-819|1|854|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-820|1|854|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-821|1|854|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-822|1|854|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-823|1|855|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-824|1|855|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-825|1|855|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-826|1|855|Neoplasia unclassified|Reproductive system,MA: 0002420 - gonad|,MPATH: 322 - teratoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-827|1|856|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-828|1|856|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-829|1|856|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-830|1|856|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-831|1|856|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-832|1|857|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-833|1|857|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-834|1|857|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-835|1|857|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-836|1|857|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-837|1|857|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-838|1|857|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-839|1|857|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-840|1|858|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-841|1|858|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-842|1|859|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-843|1|860|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-844|1|860|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-845|1|861|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-846|1|862|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-847|1|863|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-848|1|863|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-849|1|866|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-850|1|866|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-851|1|866|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-852|1|867|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-853|1|867|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-854|1|869|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-855|1|869|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-856|1|869|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-857|1|869|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-858|1|869|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-859|1|870|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-860|1|870|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-861|1|870|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-862|1|871|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-863|1|872|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-864|1|874|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-865|1|874|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-866|1|874|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-867|1|874|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-868|1|875|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-869|1|875|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-870|1|875|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-871|1|876|Neoplasia malignant|Nervous system and special sense organs,MA: 0000236 - ear|,MPATH: 218 - neoplasm|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-872|1|876|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-873|1|876|Neoplasia malignant|Other local manifestations and miscellaneus|benign|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-874|1|876|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-875|1|876|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-876|1|876|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-877|1|876|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-878|1|877|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-879|1|877|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-880|1|877|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-881|1|878|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-882|1|878|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-883|1|879|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-884|1|879|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-885|1|881|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-886|1|881|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-887|1|882|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-888|1|882|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-889|1|882|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-890|1|882|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-891|1|883|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-892|1|883|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-893|1|885|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-894|1|885|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-895|1|886|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-896|1|886|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|benign,MPATH: 219 - adnexal and skin appendage tumor|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-897|1|886|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-898|1|886|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-899|1|886|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-900|1|886|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-901|1|886|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 242 - hemangiosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-902|1|887|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-903|1|888|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-904|1|888|Neoplasia malignant|Spleen and thymus  among haematolymphatic system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-905|1|890|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-906|1|891|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-907|1|891|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-908|1|891|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-909|1|892|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-910|1|892|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-911|1|893|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-912|1|896|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-913|1|896|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-914|1|896|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-915|1|896|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-916|1|897|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-917|1|897|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-918|1|897|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-919|1|897|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-920|1|897|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-921|1|897|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-922|1|897|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-923|1|897|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-924|1|898|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-925|1|898|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-926|1|898|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-927|1|899|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-928|1|899|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-929|1|900|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-930|1|900|Neoplasia benign|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-931|1|902|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-932|1|902|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-933|1|902|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-934|1|902|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-935|1|902|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-936|1|902|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-937|1|903|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-938|1|903|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-939|1|903|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-940|1|903|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-941|1|903|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-942|1|904|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-943|1|904|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-944|1|905|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-945|1|905|Neoplasia systemic|Haematolymphatic system|benign|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-946|1|905|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-947|1|905|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-948|1|905|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-949|1|905|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-950|1|905|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-951|1|908|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-952|1|910|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-953|1|911|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-954|1|911|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-955|1|911|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-956|1|912|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-957|1|912|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-958|1|914|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-959|1|914|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-960|1|914|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-961|1|914|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-962|1|914|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-963|1|914|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-964|1|915|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-965|1|915|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-966|1|916|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-967|1|917|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-968|1|917|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|metastatic,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-969|1|918|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-970|1|918|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-971|1|918|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-972|1|919|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-973|1|919|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-974|1|919|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-975|1|919|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-976|1|919|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-977|1|919|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-978|1|919|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-979|1|919|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-980|1|919|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-981|1|919|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-982|1|919|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-983|1|919|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-984|1|919|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-985|1|923|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-986|1|923|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-987|1|924|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-988|1|924|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-989|1|924|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-990|1|924|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-991|1|925|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-992|1|926|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-993|1|926|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-994|1|926|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-995|1|927|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-996|1|927|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-997|1|927|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-998|1|928|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-999|1|930|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1000|1|931|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1001|1|931|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1002|1|931|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1003|1|931|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1004|1|932|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1005|1|933|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1006|1|933|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1007|1|933|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1008|1|934|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1009|1|934|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1010|1|934|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1011|1|934|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1012|1|934|Neoplasia benign|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1013|1|938|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1014|1|938|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1015|1|938|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1016|1|938|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1017|1|939|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1018|1|939|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1019|1|940|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1020|1|940|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1021|1|940|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1022|1|940|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1023|1|944|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1024|1|944|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1025|1|944|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1026|1|945|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|benign,MPATH: 446 - squamous cell carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1027|1|947|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1028|1|947|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1029|1|947|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1030|1|948|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1031|1|950|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1032|1|951|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1033|1|951|Hyperplastic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1034|1|951|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1035|1|951|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1036|1|953|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1037|1|953|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1038|1|953|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1039|1|953|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1040|1|954|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1041|1|954|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1042|1|955|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1043|1|957|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1044|1|959|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1045|1|959|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1046|1|959|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1047|1|959|Neoplasia malignant|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1048|1|959|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1049|1|959|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1050|1|959|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1051|1|959|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1052|1|959|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1053|1|959|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1054|1|959|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1055|1|960|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1056|1|961|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1057|1|961|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1058|1|961|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1059|1|961|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1060|1|961|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1061|1|961|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1062|1|962|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1063|1|963|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1064|1|963|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1065|1|965|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1066|1|966|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1067|1|967|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1068|1|967|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1069|1|967|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1070|1|967|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1071|1|967|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1072|1|967|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1073|1|968|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1074|1|968|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1075|1|970|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1076|1|971|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1077|1|971|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1078|1|971|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1079|1|971|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1080|1|972|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1081|1|972|Other deterministic changes|Whole body|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1082|1|974|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1083|1|974|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1084|1|974|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1085|1|974|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1086|1|974|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1087|1|974|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1088|1|975|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1089|1|976|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1090|1|976|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1091|1|978|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1092|1|979|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1093|1|979|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 219 - adnexal and skin appendage tumor|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1094|1|979|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1095|1|979|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1096|1|979|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1097|1|979|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1098|1|979|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1099|1|979|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1100|1|980|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1101|1|983|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1102|1|983|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1103|1|984|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1104|1|985|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1105|1|985|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1106|1|986|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1107|1|986|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1108|1|986|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1109|1|986|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1110|1|990|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1111|1|990|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1112|1|990|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1113|1|991|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1114|1|992|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1115|1|992|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1116|1|993|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1117|1|995|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1118|1|995|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1119|1|996|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1120|1|996|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1121|1|998|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1122|1|998|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1123|1|998|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1124|1|998|Neoplasia benign|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1125|1|998|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1126|1|1094|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1127|1|1102|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1128|1|1102|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1129|1|1102|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1130|1|1105|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1131|1|1105|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1132|1|1105|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1133|1|1105|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1134|1|1107|Other deterministic changes|Lower respiratory system|n/a|
2-1-1|Spam-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls before 12/31/81|1135 (1135 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study rats before 12/31/81|2-1-1-1135|1|1107|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-1|2|8|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-2|2|18|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-3|2|20|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-4|2|22|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-5|2|26|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-6|2|34|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-7|2|35|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-8|2|38|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-9|2|42|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-10|2|44|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-11|2|50|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-12|2|52|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-13|2|192|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-14|2|194|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-15|2|212|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-16|2|231|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-17|2|231|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-18|2|231|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-19|2|232|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-20|2|278|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-21|2|290|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-22|2|306|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-23|2|310|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-24|2|341|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-25|2|342|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-26|2|342|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-27|2|351|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-28|2|366|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-29|2|370|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|benign,MPATH: 551 - sarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-30|2|371|Neoplasia unclassified|Central nervous system among nervous system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-31|2|414|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-32|2|422|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-33|2|425|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-34|2|426|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-35|2|432|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-36|2|434|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-37|2|442|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-38|2|443|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-39|2|450|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-40|2|452|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-41|2|453|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-42|2|453|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-43|2|453|Neoplasia unclassified|Lower respiratory system,MA: 0000032 - thoracic cavity|,MPATH: 238 - hemangioblastoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-44|2|453|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|benign,MPATH: 242 - hemangiosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-45|2|455|Neoplasia benign|Bloodvessels among cardiovascular system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-46|2|455|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-47|2|457|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-48|2|460|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-49|2|460|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-50|2|464|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-51|2|470|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-52|2|472|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-53|2|477|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-54|2|483|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-55|2|486|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-56|2|488|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-57|2|492|Hyperplastic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-58|2|499|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-59|2|500|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-60|2|501|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-61|2|503|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-62|2|504|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-63|2|504|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-64|2|505|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-65|2|506|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-66|2|506|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-67|2|507|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-68|2|509|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-69|2|512|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-70|2|516|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-71|2|521|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-72|2|522|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|metastatic,MPATH: 446 - squamous cell carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-73|2|522|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-74|2|524|Neoplasia unclassified|Central nervous system among nervous system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-75|2|531|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-76|2|532|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-77|2|537|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-78|2|538|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-79|2|539|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-80|2|540|Neoplasia unclassified|Nervous system and special sense organs,MA: 0002565 - sebaceous gland|,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-81|2|541|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-82|2|541|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-83|2|542|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-84|2|543|Neoplasia malignant|Other local manifestations and miscellaneus|benign|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-85|2|544|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-86|2|545|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-87|2|545|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-88|2|547|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-89|2|549|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-90|2|549|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-91|2|550|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-92|2|550|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-93|2|551|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-94|2|551|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-95|2|553|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-96|2|558|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-97|2|561|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|metastatic,MPATH: 409 - fibrous histiocytoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-98|2|562|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-99|2|566|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-100|2|569|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-101|2|572|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-102|2|572|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-103|2|572|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-104|2|574|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-105|2|575|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-106|2|577|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-107|2|577|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-108|2|578|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-109|2|580|Neoplasia malignant|Bloodvessels among cardiovascular system|benign|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-110|2|580|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-111|2|582|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-112|2|582|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-113|2|584|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-114|2|584|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-115|2|584|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-116|2|586|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-117|2|586|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-118|2|587|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-119|2|588|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-120|2|588|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-121|2|588|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-122|2|592|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-123|2|594|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-124|2|595|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-125|2|597|Neoplasia unclassified|Thyroid and parathyroid glands among endocrine systems,MA: 0002676 - parathyroid gland capsule|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-126|2|597|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-127|2|600|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-128|2|601|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-129|2|602|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-130|2|602|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-131|2|607|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-132|2|608|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-133|2|610|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-134|2|610|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-135|2|614|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-136|2|614|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-137|2|615|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-138|2|615|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-139|2|618|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-140|2|619|Neoplasia unclassified|Nervous system and special sense organs,MA: 0002565 - sebaceous gland|,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-141|2|619|Neoplasia benign|Bloodvessels among cardiovascular system|metastatic|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-142|2|621|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-143|2|621|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-144|2|622|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-145|2|623|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-146|2|623|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-147|2|623|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-148|2|625|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-149|2|628|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-150|2|629|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|metastatic,MPATH: 426 - leiomyosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-151|2|629|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-152|2|632|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-153|2|632|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-154|2|632|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-155|2|634|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-156|2|635|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-157|2|636|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-158|2|637|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-159|2|637|Neoplasia benign|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-160|2|638|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-161|2|638|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-162|2|643|Neoplasia malignant|Other local manifestations and miscellaneus|metastatic|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-163|2|646|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-164|2|649|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|benign,MPATH: 219 - adnexal and skin appendage tumor|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-165|2|649|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-166|2|649|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-167|2|649|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-168|2|651|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-169|2|652|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-170|2|654|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-171|2|655|Neoplasia unclassified|Central nervous system among nervous system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-172|2|657|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-173|2|657|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-174|2|657|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-175|2|659|Neoplasia unclassified|Central nervous system among nervous system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-176|2|662|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-177|2|662|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-178|2|662|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-179|2|662|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-180|2|662|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-181|2|663|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-182|2|663|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-183|2|666|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-184|2|666|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-185|2|667|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-186|2|667|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-187|2|667|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-188|2|671|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-189|2|671|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-190|2|672|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-191|2|673|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-192|2|673|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-193|2|675|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-194|2|675|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-195|2|676|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-196|2|676|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-197|2|678|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-198|2|680|Neoplasia unclassified|Nervous system and special sense organs,MA: 0002565 - sebaceous gland|,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-199|2|680|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-200|2|680|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-201|2|681|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-202|2|682|Neoplasia benign|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-203|2|682|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-204|2|683|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-205|2|683|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-206|2|683|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-207|2|685|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-208|2|685|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-209|2|685|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-210|2|685|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-211|2|685|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-212|2|686|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-213|2|686|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-214|2|686|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-215|2|686|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-216|2|686|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-217|2|686|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-218|2|687|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-219|2|687|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-220|2|687|Neoplasia unclassified|Thyroid and parathyroid glands among endocrine systems,MA: 0002676 - parathyroid gland capsule|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-221|2|687|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|benign,MPATH: 549 - carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-222|2|690|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-223|2|690|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-224|2|691|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-225|2|691|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-226|2|692|Neoplasia unclassified|Thyroid and parathyroid glands among endocrine systems,MA: 0002676 - parathyroid gland capsule|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-227|2|694|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-228|2|694|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-229|2|695|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-230|2|696|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-231|2|696|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-232|2|698|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-233|2|698|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-234|2|698|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle|benign,MPATH: 268 - adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-235|2|699|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-236|2|699|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-237|2|701|Neoplasia unclassified|Nervous system and special sense organs,MA: 0002565 - sebaceous gland|,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-238|2|701|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-239|2|701|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-240|2|702|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-241|2|702|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-242|2|702|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-243|2|703|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-244|2|703|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-245|2|703|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-246|2|704|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-247|2|705|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-248|2|708|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-249|2|708|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-250|2|709|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-251|2|709|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-252|2|709|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-253|2|710|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-254|2|710|Neoplasia malignant|Other local manifestations and miscellaneus|benign|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-255|2|712|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-256|2|712|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-257|2|713|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-258|2|713|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-259|2|714|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-260|2|716|Neoplasia unclassified|Reproductive system,MA: 0002420 - gonad|,MPATH: 322 - teratoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-261|2|717|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-262|2|717|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-263|2|718|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-264|2|718|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-265|2|722|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-266|2|722|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-267|2|722|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-268|2|723|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-269|2|724|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-270|2|724|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-271|2|725|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-272|2|725|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-273|2|725|Hyperplastic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-274|2|726|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-275|2|727|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-276|2|727|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-277|2|727|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-278|2|727|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-279|2|728|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-280|2|729|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-281|2|729|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-282|2|729|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-283|2|731|Neoplasia unclassified|Thyroid and parathyroid glands among endocrine systems,MA: 0002676 - parathyroid gland capsule|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-284|2|731|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-285|2|732|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-286|2|732|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-287|2|732|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-288|2|732|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-289|2|732|Neoplasia unclassified|Nervous system and special sense organs,MA: 0002565 - sebaceous gland|,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-290|2|733|Neoplasia unclassified|Thyroid and parathyroid glands among endocrine systems,MA: 0002676 - parathyroid gland capsule|,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-291|2|733|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-292|2|733|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-293|2|734|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-294|2|736|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-295|2|736|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-296|2|736|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-297|2|737|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-298|2|737|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-299|2|737|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-300|2|739|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-301|2|740|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-302|2|740|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-303|2|743|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-304|2|743|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-305|2|743|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-306|2|743|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-307|2|743|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-308|2|744|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-309|2|744|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-310|2|745|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-311|2|745|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-312|2|746|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-313|2|746|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-314|2|749|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-315|2|749|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-316|2|750|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-317|2|751|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-318|2|751|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-319|2|753|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-320|2|753|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-321|2|753|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-322|2|754|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-323|2|754|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-324|2|754|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-325|2|754|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-326|2|755|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-327|2|757|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-328|2|759|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-329|2|760|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-330|2|760|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-331|2|761|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-332|2|761|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-333|2|761|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-334|2|762|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-335|2|763|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-336|2|764|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-337|2|764|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-338|2|764|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-339|2|764|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-340|2|765|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-341|2|765|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-342|2|765|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-343|2|767|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-344|2|767|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-345|2|767|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-346|2|769|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-347|2|769|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-348|2|770|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-349|2|770|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-350|2|771|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-351|2|771|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-352|2|771|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-353|2|771|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-354|2|771|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-355|2|772|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-356|2|773|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-357|2|774|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-358|2|774|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-359|2|774|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-360|2|774|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-361|2|775|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-362|2|776|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-363|2|776|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-364|2|777|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-365|2|778|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-366|2|778|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-367|2|779|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-368|2|780|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-369|2|781|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-370|2|781|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-371|2|781|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|metastatic,MPATH: 551 - sarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-372|2|782|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-373|2|782|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-374|2|785|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-375|2|785|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-376|2|786|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|benign,MPATH: 551 - sarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-377|2|786|Neoplasia malignant|Other local manifestations and miscellaneus|metastatic|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-378|2|787|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-379|2|787|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-380|2|788|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-381|2|788|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-382|2|788|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-383|2|789|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-384|2|790|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-385|2|792|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-386|2|792|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-387|2|792|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-388|2|792|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-389|2|792|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-390|2|793|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-391|2|793|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-392|2|794|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-393|2|794|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|benign,MPATH: 551 - sarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-394|2|794|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-395|2|795|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-396|2|795|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-397|2|795|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-398|2|796|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-399|2|796|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-400|2|796|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-401|2|797|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-402|2|798|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-403|2|798|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-404|2|799|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-405|2|799|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-406|2|799|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-407|2|799|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-408|2|801|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-409|2|801|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-410|2|801|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-411|2|802|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-412|2|802|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-413|2|802|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-414|2|803|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-415|2|803|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-416|2|803|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-417|2|803|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-418|2|806|Neoplasia unclassified|Central nervous system among nervous system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-419|2|806|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-420|2|806|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-421|2|807|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-422|2|808|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-423|2|809|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-424|2|811|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-425|2|811|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-426|2|813|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-427|2|813|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-428|2|813|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-429|2|813|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-430|2|813|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-431|2|813|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-432|2|814|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-433|2|816|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-434|2|816|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-435|2|816|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-436|2|816|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-437|2|818|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-438|2|818|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-439|2|820|Neoplasia benign|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-440|2|820|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-441|2|821|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-442|2|821|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-443|2|822|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-444|2|822|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-445|2|822|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-446|2|823|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-447|2|823|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-448|2|824|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-449|2|825|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-450|2|825|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-451|2|826|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-452|2|828|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-453|2|829|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-454|2|830|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-455|2|830|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-456|2|830|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-457|2|831|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-458|2|831|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|metastatic,MPATH: 549 - carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-459|2|832|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-460|2|833|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-461|2|833|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-462|2|834|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-463|2|834|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-464|2|834|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-465|2|835|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-466|2|835|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-467|2|835|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-468|2|836|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-469|2|837|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-470|2|837|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-471|2|837|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-472|2|838|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-473|2|838|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-474|2|838|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-475|2|838|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-476|2|838|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-477|2|838|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-478|2|840|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|metastatic,MPATH: 549 - carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-479|2|841|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-480|2|841|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-481|2|841|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-482|2|841|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-483|2|842|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-484|2|842|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-485|2|842|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-486|2|842|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 242 - hemangiosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-487|2|842|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-488|2|843|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-489|2|843|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-490|2|844|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-491|2|844|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-492|2|844|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-493|2|844|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-494|2|845|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-495|2|846|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-496|2|846|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-497|2|848|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-498|2|848|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-499|2|848|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-500|2|848|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-501|2|849|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-502|2|849|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-503|2|849|Neoplasia unclassified|Thyroid and parathyroid glands among endocrine systems,MA: 0002676 - parathyroid gland capsule|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-504|2|850|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-505|2|851|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-506|2|851|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-507|2|851|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-508|2|852|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-509|2|852|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-510|2|852|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-511|2|852|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-512|2|853|Neoplasia unclassified|Central nervous system among nervous system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-513|2|853|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-514|2|854|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-515|2|855|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-516|2|855|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-517|2|856|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-518|2|856|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-519|2|857|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-520|2|857|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-521|2|857|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-522|2|858|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-523|2|858|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-524|2|858|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-525|2|859|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-526|2|859|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-527|2|859|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-528|2|859|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-529|2|861|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-530|2|862|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-531|2|862|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-532|2|863|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-533|2|865|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-534|2|865|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-535|2|866|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-536|2|866|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-537|2|866|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-538|2|866|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-539|2|866|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-540|2|866|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-541|2|867|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-542|2|868|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-543|2|868|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-544|2|868|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-545|2|868|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-546|2|869|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-547|2|869|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-548|2|869|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-549|2|871|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-550|2|873|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-551|2|873|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-552|2|874|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-553|2|876|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-554|2|876|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-555|2|876|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-556|2|876|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-557|2|877|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-558|2|880|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-559|2|881|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-560|2|881|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-561|2|883|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-562|2|883|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-563|2|883|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-564|2|884|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-565|2|886|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-566|2|886|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-567|2|886|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-568|2|887|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-569|2|887|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-570|2|887|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-571|2|888|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-572|2|888|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-573|2|888|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-574|2|888|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-575|2|889|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-576|2|889|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-577|2|890|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-578|2|890|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-579|2|890|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-580|2|892|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-581|2|892|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-582|2|892|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-583|2|892|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-584|2|892|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-585|2|892|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-586|2|892|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-587|2|896|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-588|2|897|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-589|2|897|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-590|2|897|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-591|2|898|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-592|2|898|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-593|2|898|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-594|2|898|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-595|2|902|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-596|2|904|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-597|2|904|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-598|2|905|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-599|2|905|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-600|2|905|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-601|2|906|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-602|2|907|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-603|2|908|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-604|2|909|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-605|2|909|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-606|2|909|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-607|2|909|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-608|2|910|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|metastatic,MPATH: 219 - adnexal and skin appendage tumor|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-609|2|911|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-610|2|911|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-611|2|911|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-612|2|911|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-613|2|912|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-614|2|912|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-615|2|914|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-616|2|914|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-617|2|915|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-618|2|915|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-619|2|915|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-620|2|915|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-621|2|918|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-622|2|918|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-623|2|920|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-624|2|922|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-625|2|923|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-626|2|925|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-627|2|928|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-628|2|928|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-629|2|929|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-630|2|929|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-631|2|930|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-632|2|932|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-633|2|932|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-634|2|932|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-635|2|932|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-636|2|932|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-637|2|934|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-638|2|934|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-639|2|934|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-640|2|934|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-641|2|934|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-642|2|934|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-643|2|936|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-644|2|937|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|metastatic,MPATH: 513 - Lymphoid neoplasms|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-645|2|937|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-646|2|937|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-647|2|938|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-648|2|938|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-649|2|938|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-650|2|943|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-651|2|943|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-652|2|946|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-653|2|948|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-654|2|949|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-655|2|949|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-656|2|950|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-657|2|950|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-658|2|951|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|metastatic,MPATH: 549 - carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-659|2|953|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-660|2|953|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-661|2|955|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-662|2|955|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-663|2|957|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-664|2|957|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-665|2|958|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-666|2|959|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-667|2|959|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-668|2|966|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-669|2|966|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-670|2|972|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-671|2|972|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-672|2|972|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-673|2|973|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-674|2|974|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-675|2|976|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-676|2|979|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-677|2|981|Other deterministic changes|Lower respiratory system|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-678|2|981|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-679|2|982|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-680|2|982|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-681|2|983|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-682|2|985|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-683|2|996|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-684|2|999|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-685|2|999|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-686|2|1057|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-687|2|1078|Other deterministic changes|Whole body|n/a|
2-1-2|Spbm-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls after 1/1/82|688 (688 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Unknown|lifespan study after 12/31/81|2-1-2-688|2|1079|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-1|3|17|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-2|3|38|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|metastatic,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-3|3|38|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-4|3|44|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-5|3|51|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|metastatic,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-6|3|51|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-7|3|51|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-8|3|60|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-9|3|60|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-10|3|60|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-11|3|60|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-12|3|60|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-13|3|60|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-14|3|73|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-15|3|206|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-16|3|206|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-17|3|206|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-18|3|206|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-19|3|206|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-20|3|206|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-21|3|258|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-22|3|258|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-23|3|258|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-24|3|258|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-25|3|258|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-26|3|258|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-27|3|306|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-28|3|306|Hyperplastic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-29|3|306|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-30|3|306|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-31|3|306|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-32|3|306|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-33|3|326|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-34|3|396|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-35|3|401|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-36|3|413|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|metastatic,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-37|3|454|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-38|3|457|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-39|3|457|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-40|3|461|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-41|3|462|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-42|3|475|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-43|3|478|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-44|3|484|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-45|3|488|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-46|3|494|Neoplasia malignant|Spleen and thymus  among haematolymphatic system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-47|3|495|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-48|3|503|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-49|3|503|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-50|3|503|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-51|3|510|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|metastatic,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-52|3|525|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-53|3|525|Neoplasia malignant|Reproductive system,MA: 0000396 - male reproductive system|,MPATH: 551 - sarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-54|3|527|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-55|3|533|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-56|3|534|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-57|3|536|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-58|3|536|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-59|3|536|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-60|3|540|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-61|3|541|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-62|3|550|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 551 - sarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-63|3|551|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-64|3|555|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-65|3|558|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-66|3|564|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-67|3|575|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-68|3|575|Hyperplastic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-69|3|576|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-70|3|576|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-71|3|576|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-72|3|576|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-73|3|576|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-74|3|576|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-75|3|576|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-76|3|576|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-77|3|577|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-78|3|577|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-79|3|577|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-80|3|577|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-81|3|577|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-82|3|577|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-83|3|577|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-84|3|577|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-85|3|577|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-86|3|577|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-87|3|577|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-88|3|577|Other deterministic changes|Whole body|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-89|3|589|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-90|3|592|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-91|3|602|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-92|3|613|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-93|3|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-94|3|616|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-95|3|618|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-96|3|620|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-97|3|622|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-98|3|622|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-99|3|624|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-100|3|634|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-101|3|640|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-102|3|645|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-103|3|646|Neoplasia malignant|Other local manifestations and miscellaneus|metastatic|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-104|3|650|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-105|3|651|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-106|3|651|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-107|3|653|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-108|3|655|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-109|3|655|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-110|3|657|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-111|3|657|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-112|3|661|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-113|3|666|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-114|3|667|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-115|3|667|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-116|3|667|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-117|3|671|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-118|3|678|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-119|3|681|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-120|3|685|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-121|3|687|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-122|3|687|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-123|3|688|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|metastatic,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-124|3|688|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-125|3|689|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-126|3|694|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-127|3|701|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-128|3|703|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-129|3|703|Neoplasia malignant|Liver among hepato-pancreatic system diseases|benign|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-130|3|703|Neoplasia malignant|Reproductive system,MA: 0000396 - male reproductive system|,MPATH: 551 - sarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-131|3|708|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-132|3|714|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-133|3|714|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-134|3|714|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-135|3|716|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-136|3|716|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-137|3|720|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-138|3|720|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|metastatic,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-139|3|727|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-140|3|728|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-141|3|729|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-142|3|732|Neoplasia malignant|Bloodvessels among cardiovascular system|benign|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-143|3|735|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-144|3|735|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-145|3|735|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-146|3|737|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-147|3|742|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|benign,MPATH: 549 - carcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-148|3|742|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-149|3|743|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-150|3|743|Neoplasia malignant|Other local manifestations and miscellaneus|benign|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-151|3|743|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-152|3|743|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-153|3|745|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-154|3|750|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-155|3|755|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-156|3|755|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-157|3|757|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-158|3|757|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-159|3|766|Neoplasia malignant|Liver among hepato-pancreatic system diseases|benign|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-160|3|770|Neoplasia malignant|Bloodvessels among cardiovascular system|benign|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-161|3|773|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-162|3|774|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-163|3|777|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-164|3|778|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-165|3|779|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-166|3|780|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-167|3|781|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-168|3|783|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-169|3|783|Neoplasia malignant|Bloodvessels among cardiovascular system|benign|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-170|3|785|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-171|3|785|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-172|3|786|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-173|3|786|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-174|3|789|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-175|3|792|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|metastatic,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-176|3|793|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-177|3|794|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-178|3|797|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-179|3|799|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-180|3|800|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-181|3|809|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-182|3|811|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-183|3|811|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-184|3|812|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|metastatic,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-185|3|812|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-186|3|813|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-187|3|814|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-188|3|818|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-189|3|819|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-190|3|819|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-191|3|819|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-192|3|823|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-193|3|828|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-194|3|828|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-195|3|829|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-196|3|833|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-197|3|833|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-198|3|835|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-199|3|835|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-200|3|838|Neoplasia malignant|Reproductive system,MA: 0000381 - female reproductive system|benign,MPATH: 551 - sarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-201|3|844|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-202|3|853|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-203|3|864|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-204|3|866|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-205|3|869|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-206|3|869|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-207|3|871|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-208|3|873|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-209|3|876|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-210|3|876|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-211|3|884|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|metastatic,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-212|3|885|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-213|3|889|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-214|3|895|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|metastatic,MPATH: 549 - carcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-215|3|902|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-216|3|902|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-217|3|905|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-218|3|910|Neoplasia malignant|Bloodvessels among cardiovascular system|benign|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-219|3|915|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-220|3|919|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-221|3|920|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-222|3|920|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-223|3|920|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-224|3|920|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-225|3|925|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-226|3|930|Neoplasia malignant|Reproductive system,MA: 0000381 - female reproductive system|benign,MPATH: 551 - sarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-227|3|935|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-228|3|951|Other deterministic changes|Lower respiratory system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-229|3|956|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-230|3|959|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|metastatic,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-231|3|959|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-232|3|959|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-233|3|961|Neoplasia malignant|Bloodvessels among cardiovascular system|benign|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-234|3|977|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-235|3|987|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|metastatic,MPATH: 549 - carcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-236|3|998|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-237|3|998|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-238|3|1130|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-239|3|1151|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-3|Spf-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|240 (240 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Unknown|lifespan study|2-1-3-240|3|1155|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-1|4|3|Hyperplastic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-2|4|3|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-3|4|4|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-4|4|6|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-5|4|8|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-6|4|12|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-7|4|14|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-8|4|15|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-9|4|15|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-10|4|17|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-11|4|18|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-12|4|19|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-13|4|20|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-14|4|27|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-15|4|33|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-16|4|40|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-17|4|46|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-18|4|50|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-19|4|53|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-20|4|55|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-21|4|56|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-22|4|60|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-23|4|68|Hyperplastic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-24|4|70|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-25|4|76|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-26|4|78|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-27|4|78|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-28|4|78|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-29|4|78|Neoplasia malignant|Lower respiratory system,MA: 0000032 - thoracic cavity|,MPATH: 551 - sarcoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-30|4|80|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-31|4|83|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-32|4|83|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-33|4|88|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-34|4|199|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-35|4|199|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-36|4|202|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-37|4|271|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-38|4|300|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-39|4|321|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-40|4|366|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-41|4|368|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-42|4|370|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-43|4|383|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-44|4|388|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-45|4|388|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-46|4|390|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-47|4|418|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-48|4|427|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-49|4|430|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-50|4|438|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-51|4|452|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-52|4|455|Neoplasia malignant|Spleen and thymus  among haematolymphatic system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-53|4|463|Hyperplastic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-54|4|468|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-55|4|468|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-56|4|469|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-57|4|479|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-58|4|480|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-59|4|482|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-60|4|484|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-61|4|494|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-62|4|512|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-63|4|512|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-64|4|512|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-65|4|512|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-66|4|513|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-67|4|520|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-68|4|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|metastatic,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-69|4|562|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-70|4|574|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-71|4|586|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-72|4|587|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-73|4|591|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-74|4|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-75|4|592|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-76|4|601|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-77|4|605|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-78|4|607|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-79|4|607|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-80|4|607|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-81|4|615|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-82|4|621|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-83|4|624|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-84|4|630|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-85|4|633|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-86|4|635|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-87|4|643|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-88|4|643|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-89|4|643|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-90|4|647|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-91|4|650|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-92|4|653|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-93|4|653|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-94|4|653|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-95|4|653|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-96|4|659|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-97|4|665|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-98|4|669|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-99|4|670|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-100|4|673|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-101|4|674|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-102|4|679|Neoplasia malignant|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-103|4|680|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-104|4|681|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-105|4|682|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-106|4|683|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-107|4|688|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-108|4|688|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-109|4|688|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-110|4|688|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-111|4|688|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-112|4|688|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-113|4|688|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-114|4|695|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-115|4|695|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-116|4|696|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-117|4|698|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-118|4|698|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-119|4|698|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-120|4|704|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-121|4|704|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-122|4|705|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-123|4|706|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-124|4|713|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-125|4|713|Hyperplastic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-126|4|715|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 491 - polyp|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-127|4|717|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-128|4|723|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-129|4|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-130|4|725|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-131|4|725|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-132|4|726|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-133|4|727|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-134|4|730|Neoplasia benign|Upper digestive tract|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-135|4|730|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|,MPATH: 242 - hemangiosarcoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-136|4|737|Neoplasia malignant|Heart among cardiovascular system,MA: 0000072 - heart|,MPATH: 511 - Myeloproliferation (genetic)|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-137|4|737|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-138|4|740|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-139|4|741|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-140|4|742|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|benign,MPATH: 551 - sarcoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-141|4|742|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-142|4|743|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-143|4|746|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-144|4|746|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-145|4|748|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-146|4|749|Hyperplastic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-147|4|749|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-148|4|749|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-149|4|751|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-150|4|755|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-151|4|757|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-152|4|763|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-153|4|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-154|4|764|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-155|4|765|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-156|4|769|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-157|4|771|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-158|4|772|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-159|4|774|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-160|4|775|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-161|4|775|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-162|4|775|Neoplasia malignant|Spleen and thymus  among haematolymphatic system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-163|4|777|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-164|4|777|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-165|4|777|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-166|4|777|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-167|4|779|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-168|4|779|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-169|4|780|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-170|4|787|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-171|4|794|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-172|4|795|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-173|4|797|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-174|4|798|Hyperplastic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-175|4|799|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-176|4|800|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-177|4|805|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|benign,MPATH: 428 - rhabdomyosarcoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-178|4|806|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-179|4|806|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-180|4|809|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-181|4|810|Other deterministic changes|Whole body|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-182|4|819|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-183|4|824|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-184|4|824|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-185|4|827|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-186|4|827|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-187|4|829|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-188|4|834|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-189|4|835|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-190|4|838|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-191|4|841|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-192|4|844|Hyperplastic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-193|4|847|Hyperplastic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-194|4|849|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-195|4|851|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-196|4|854|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-197|4|854|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-198|4|854|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-199|4|857|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-200|4|857|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-201|4|858|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-202|4|858|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-203|4|859|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-204|4|864|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-205|4|866|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-206|4|867|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-207|4|869|Neoplasia benign|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-208|4|870|Neoplasia benign|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-209|4|870|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-210|4|870|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-211|4|870|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-212|4|871|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-213|4|871|Neoplasia benign|Lower respiratory system,MA: 0000415 - lung|,MPATH: 425 - leiomyoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-214|4|872|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-215|4|874|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-216|4|875|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-217|4|875|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-218|4|876|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-219|4|878|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-220|4|882|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-221|4|885|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|benign,MPATH: 549 - carcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-222|4|886|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-223|4|886|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-224|4|887|Neoplasia malignant|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 549 - carcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-225|4|887|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-226|4|889|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-227|4|889|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-228|4|889|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-229|4|890|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-230|4|894|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-231|4|896|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-232|4|897|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|benign,MPATH: 218 - neoplasm|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-233|4|899|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-234|4|900|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-235|4|902|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-236|4|902|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-237|4|902|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-238|4|905|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-239|4|905|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-240|4|906|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-241|4|906|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-242|4|906|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-243|4|910|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-244|4|910|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-245|4|912|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-246|4|915|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-247|4|920|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-248|4|921|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-249|4|921|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-250|4|922|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-251|4|922|Hyperplastic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-252|4|923|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-253|4|923|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-254|4|924|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-255|4|925|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-256|4|928|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-257|4|928|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-258|4|931|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-259|4|937|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-260|4|939|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-261|4|940|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-262|4|940|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-263|4|942|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-264|4|942|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-265|4|944|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-266|4|950|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-267|4|950|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-268|4|951|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-269|4|956|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-270|4|956|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-271|4|957|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-272|4|958|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-273|4|959|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-274|4|959|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-275|4|959|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-276|4|959|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-277|4|960|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-278|4|961|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-279|4|964|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-280|4|965|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-281|4|965|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-282|4|968|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-283|4|970|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-284|4|970|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-285|4|972|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-286|4|974|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-287|4|978|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-288|4|978|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-289|4|980|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-290|4|980|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-291|4|982|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-292|4|985|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-293|4|986|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-294|4|987|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-295|4|988|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-296|4|990|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-297|4|992|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-298|4|993|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-299|4|1095|Hyperplastic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-300|4|1111|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-301|4|1114|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-302|4|1114|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-303|4|1114|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-304|4|1114|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|benign,MPATH: 278 - follicular adenocarcinoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-305|4|1114|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-306|4|1114|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-307|4|1126|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-308|4|1129|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-309|4|1136|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-310|4|1149|Other deterministic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-311|4|1187|Hyperplastic changes|Lower respiratory system|n/a|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-312|4|1194|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-1-4|Wim-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|313 (313 in ERA)|Rat|Rat Wistar|Male|Unknown|lifespan study|2-1-4-313|4|1204|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-1|5|2|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-2|5|3|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-3|5|7|Hyperplastic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-4|5|7|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-5|5|8|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-6|5|12|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-7|5|13|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-8|5|18|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-9|5|22|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-10|5|24|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-11|5|25|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-12|5|27|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-13|5|29|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-14|5|29|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-15|5|31|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-16|5|37|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-17|5|38|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-18|5|42|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-19|5|43|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-20|5|45|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-21|5|45|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-22|5|46|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-23|5|48|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-24|5|49|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-25|5|50|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-26|5|59|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-27|5|60|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-28|5|60|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-29|5|67|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-30|5|67|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-31|5|71|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-32|5|71|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-33|5|76|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-34|5|76|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-35|5|86|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-36|5|86|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-37|5|90|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-38|5|193|Neoplasia malignant|Reproductive system,MA: 0000404 - prostate gland|benign,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-39|5|193|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-40|5|197|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-41|5|204|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-42|5|213|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-43|5|216|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-44|5|224|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-45|5|224|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-46|5|225|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-47|5|228|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-48|5|230|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-49|5|231|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-50|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-51|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-52|5|249|Hyperplastic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-53|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-54|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-55|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-56|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-57|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-58|5|249|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-59|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-60|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-61|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-62|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-63|5|249|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-64|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-65|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-66|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-67|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-68|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-69|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-70|5|249|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-71|5|347|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-72|5|369|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-73|5|419|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-74|5|430|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-75|5|458|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-76|5|470|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-77|5|475|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-78|5|483|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-79|5|483|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-80|5|495|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-81|5|496|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-82|5|508|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-83|5|530|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-84|5|532|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-85|5|533|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-86|5|549|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-87|5|550|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-88|5|551|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-89|5|552|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-90|5|554|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-91|5|555|Hyperplastic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-92|5|562|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-93|5|562|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-94|5|574|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-95|5|575|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-96|5|580|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-97|5|582|Hyperplastic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-98|5|605|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-99|5|616|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-100|5|627|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-101|5|627|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-102|5|639|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-103|5|646|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-104|5|649|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-105|5|654|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-106|5|657|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-107|5|659|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-108|5|663|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-109|5|670|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-110|5|671|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-111|5|672|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-112|5|672|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-113|5|681|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-114|5|682|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-115|5|691|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-116|5|692|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-117|5|700|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-118|5|708|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-119|5|714|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-120|5|714|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-121|5|715|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-122|5|720|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-123|5|722|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-124|5|727|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-125|5|727|Neoplasia benign|Bloodvessels among cardiovascular system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-126|5|730|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-127|5|736|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-128|5|736|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-129|5|736|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-130|5|740|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-131|5|743|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-132|5|747|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-133|5|748|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-134|5|749|Hyperplastic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-135|5|749|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-136|5|755|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-137|5|765|Neoplasia unclassified|Reproductive system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-138|5|767|Neoplasia malignant|Reproductive system,MA: 0000381 - female reproductive system|,MPATH: 551 - sarcoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-139|5|768|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-140|5|770|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-141|5|774|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-142|5|778|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-143|5|778|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-144|5|780|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-145|5|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-146|5|788|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-147|5|788|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-148|5|799|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-149|5|799|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-150|5|799|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-151|5|807|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-152|5|810|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-153|5|814|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-154|5|820|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-155|5|825|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-156|5|827|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-157|5|832|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-158|5|832|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-159|5|839|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-160|5|841|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-161|5|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-162|5|843|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-163|5|844|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-164|5|844|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-165|5|847|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-166|5|859|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-167|5|859|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-168|5|859|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-169|5|862|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-170|5|869|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-171|5|871|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-172|5|871|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-173|5|876|Hyperplastic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-174|5|878|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-175|5|879|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-176|5|880|Hyperplastic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-177|5|885|Other deterministic changes|Whole body|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-178|5|886|Other deterministic changes|Whole body|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-179|5|889|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-180|5|890|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-181|5|890|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-182|5|890|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-183|5|891|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-184|5|894|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-185|5|894|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-186|5|897|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-187|5|899|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-188|5|900|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-189|5|900|Neoplasia malignant|Reproductive system,MA: 0000381 - female reproductive system|,MPATH: 551 - sarcoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-190|5|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-191|5|904|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-192|5|906|Neoplasia systemic|Haematolymphatic system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-193|5|908|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-194|5|909|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-195|5|913|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-196|5|914|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-197|5|914|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-198|5|915|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-199|5|915|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-200|5|916|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-201|5|917|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-202|5|929|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-203|5|929|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-204|5|932|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-205|5|933|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-206|5|938|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-207|5|939|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-208|5|939|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-209|5|944|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-210|5|950|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-211|5|955|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-212|5|960|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-213|5|960|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-214|5|964|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-215|5|966|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-216|5|972|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-217|5|974|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-218|5|975|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-219|5|977|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-220|5|981|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-221|5|985|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-222|5|987|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-223|5|991|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-224|5|992|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-225|5|992|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-226|5|997|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-227|5|1092|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-228|5|1093|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-229|5|1093|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-230|5|1094|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-231|5|1096|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-232|5|1099|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-233|5|1104|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-234|5|1109|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-235|5|1113|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-236|5|1116|Neoplasia malignant|Reproductive system,MA: 0000396 - male reproductive system|,MPATH: 551 - sarcoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-237|5|1120|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-238|5|1122|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-239|5|1124|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-240|5|1124|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-241|5|1129|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-242|5|1131|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-243|5|1144|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-244|5|1145|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-245|5|1152|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-246|5|1153|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-247|5|1153|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-248|5|1156|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-249|5|1167|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-250|5|1176|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-251|5|1176|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-252|5|1178|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-253|5|1180|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-254|5|1180|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-255|5|1183|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-256|5|1185|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-257|5|1222|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-258|5|1229|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-259|5|1252|Other deterministic changes|Lower respiratory system|n/a|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-260|5|1258|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-261|5|1274|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-1-5|Wif-WLM 0,n/a|1|n/a|none (controls)|0|working level months|Inhalation|historical controls|262 (262 in ERA)|Rat|Rat Wistar|Female|Unknown|lifespan study|2-1-5-262|5|1310|Other deterministic changes|Lower respiratory system|n/a|
